Penumbra (PEN) Cost of Revenue (2014 - 2026)
Penumbra (PEN) posted quarterly Cost of Revenue of $125.1 million for Q2 2026, up 8.37% year-over-year from $115.4 million in Q2 2025, and up 3.09% quarter-over-quarter from $121.3 million in Q1 2026.
Penumbra (PEN) Cost of Revenue (2014 - 2026) Analysis & Trends
Penumbra (PEN) has reported Cost of Revenue for 13 consecutive years, with $125.1 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Cost of Revenue rose 8.37% year-over-year to $125.1 million; the TTM figure through Jun 2026 stood at $484.0 million (up 12.75% YoY), while the FY2025 annual figure was $461.2 million, up 4.92% from the prior year.
- Cost of Revenue improved to $125.1 million in Q2 2026 per PEN's latest filing, from $121.3 million in the prior quarter.
- Across five years, Cost of Revenue topped out at $136.6 million in Q2 2024 and bottomed at $74.3 million in Q2 2022.
- Historically, Cost of Revenue has averaged $102.0 million across 5 years, with a median of $99.2 million in 2023.
- Annual changes were most pronounced in 2024 — Cost of Revenue jumped 44.31% — and 2025, when it retreated 15.47%.
- Penumbra's Cost of Revenue stood at $82.8 million in 2022, then climbed by 18.0% to $97.7 million in 2023, then climbed by 7.28% to $104.8 million in 2024, then increased by 17.62% to $123.3 million in 2025, then rose by 1.5% to $125.1 million in 2026.
- Business Quant data shows PEN's Cost of Revenue at $125.1 million in Q2 2026, $121.3 million in Q1 2026, and $123.3 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 5.33 Bn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 2.09 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 3.40 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 1.59 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 392.40 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 478.40 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 2.57 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 808.60 Mn |
| 10 | Penumbra | 12.81 Bn | 12.15 Bn | 264.94 Mn | 125.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 125.10 Mn |
| Jun 30, 2026 | 125.10 Mn |
| Mar 31, 2026 | 121.35 Mn |
| Mar 31, 2026 | 121.35 Mn |
| Dec 31, 2025 | 123.26 Mn |
| Dec 31, 2025 | 123.26 Mn |
| Sep 30, 2025 | 114.27 Mn |
| Sep 30, 2025 | 114.27 Mn |
| Jun 30, 2025 | 115.45 Mn |
| Jun 30, 2025 | 115.45 Mn |
| Mar 31, 2025 | 108.26 Mn |
| Mar 31, 2025 | 108.26 Mn |
| Dec 31, 2024 | 104.80 Mn |
| Dec 31, 2024 | 104.80 Mn |
| Sep 30, 2024 | 100.73 Mn |
| Sep 30, 2024 | 100.73 Mn |
| Jun 30, 2024 | 136.57 Mn |
| Jun 30, 2024 | 136.57 Mn |
| Mar 31, 2024 | 97.52 Mn |
| Mar 31, 2024 | 97.52 Mn |